Hesperidin Suppressed Proliferations of both Human Breast Cancer and Androgen-dependent Prostate Cancer Cells

被引:71
|
作者
Lee, Choong Jae [1 ,2 ]
Wilson, Leslie [2 ]
Jordan, Mary Ann [2 ]
Nguyen, Vy [2 ]
Tang, Jessica [2 ]
Smiyun, Gregory [2 ]
机构
[1] Chungnam Natl Univ, Dept Pharmacol, Coll Med, Taejon, South Korea
[2] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA
关键词
hesperidin; MCF-7; mitosis; LNCaP; prostate cancer; cytotoxicity; ANTICANCER ACTIVITY; INHIBITION; LYMPHEDEMA; MECHANISM; SECONDARY; DYNAMICS; BAICALIN; ARREST;
D O I
10.1002/ptr.2856
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hesperidin, a flavonoid derived from citrus fruits, has been reported to show various biological effects including anticancer activity. This study investigated whether hesperidin affected the proliferation of MCF-7 human breast cancer cells transfected with green fluorescent protein (GFP)/alpha-tubulin (MCF-7-GFP-Tubulin cells), androgen-independent PC-3 and DU-145 prostate cancer cells, and androgen-dependent LNCaP prostate cancer cells. The results were as follows. (1) Hesperidin inhibited the proliferation of MCF-7-GFP-Tubulin cells, probably not through an antimitotic mechanism. (2) Hesperidin also inhibited both basal and testosterone-induced proliferation of LNCaP cells. (3) However, hesperidin did not significantly affect the cell proliferation of two hormone-independent prostate cancer cells, PC-3 and DU-145. It is concluded that hesperidin can inhibit the proliferation of breast cancer cells through mechanisms other than antimitosis and it is suggested that hesperidin be further investigated for the possible interaction with androgenic receptors and involvement in signaling pathway after receptor binding in prostate cancer cells through future research. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:S15 / S19
页数:5
相关论文
共 50 条
  • [1] Androgen-dependent Activation of Human Cytomegalovirus IE promoter in Prostate Cancer Cells
    Moon, Jong-seok
    Lee, Min-young
    Park, Byeong-woo
    Kim, Kyung-sup
    FASEB JOURNAL, 2008, 22
  • [2] Oncostatic activity of a thiazolidinedione derivative on human androgen-dependent prostate cancer cells
    Moretti, RM
    Marelli, MM
    Motta, M
    Limonta, P
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (05) : 733 - 737
  • [3] Therapeutic potential of curcumin in human prostate cancer—I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells
    T Dorai
    N Gehani
    A Katz
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 84 - 93
  • [4] Therapeutic potential of curcumin in human prostate cancer - I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells
    Dorai, T
    Gehani, N
    Katz, A
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (02) : 84 - 93
  • [5] Anticancer Effect of Theranekron® on Androgen-Dependent Prostate Cancer Cells
    Erzurumlu, Yalcin
    Dogan, Hatice Kubra
    Catakli, Deniz
    TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 20 (06) : 368 - 373
  • [6] Identification of an antibody fragment specific for androgen-dependent prostate cancer cells
    Williams, Ryan M.
    Hajiran, Cyrus J.
    Nayeem, Sara
    Sooter, Letha J.
    BMC BIOTECHNOLOGY, 2014, 14
  • [7] Identification of an antibody fragment specific for androgen-dependent prostate cancer cells
    Ryan M Williams
    Cyrus J Hajiran
    Sara Nayeem
    Letha J Sooter
    BMC Biotechnology, 14
  • [8] Arsenic trioxide enhances radiation sensitivity of androgen-dependent and -independent human prostate cancer cells
    Wang, Ying-Jan
    Chiu, Hui-Wen
    Chen, Yi-An
    Ho, Sheng-Yow
    UNDERSTANDING THE GEOLOGICAL AND MEDICAL INTERFACE OF ARSENIC, AS 2012, 2012, : 206 - 208
  • [9] Enhancement of androgen-dependent transcription and cell proliferation by tributyltin and triphenyltin in human prostate cancer cells
    Yamabe, Y
    Hoshino, A
    Imura, N
    Suzuki, T
    Himeno, S
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 169 (02) : 177 - 184
  • [10] APOPTOSIS OF HUMAN ANDROGEN-DEPENDENT PROSTATE CANCER LNCAP CELLS TREATED WITH ANDROGEN RECEPTOR ELEMENT DECOY OLIGONUCLEOTIDES
    Lifeng, Y.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 218 - 218